The number of older Americans using vaping marijuana has nearly doubled in the past three years, according to new research supported by the American Association of Retired Persons (AARP). Most respondents said their main reasons for vaping marijuana include pain relief, improved sleep, and mental health.
More than one in five Americans over the age of 50 have used marijuana at least once in the past year, and more than one in ten use it at least once a month, according to a University of Michigan survey. As more states move toward legalizing marijuana, researchers expect usage among older adults to continue to rise.
Among the respondents who used cannabis in the past year, 81% said it was for relaxation, 68% used it as a sleep aid, and 64% reported using it simply to enjoy the effects. Additionally, 63% indicated they used cannabis to relieve pain, while 53% said it helped promote mental health.
Jeffrey Kullgren, a professor at the University of Michigan and a doctor at the VA Ann Arbor Healthcare System, led the recent survey. He emphasized the importance of discussing cannabis use with healthcare providers to identify potential drug interactions and signs of problematic use.
Kullgren stated, “Even if your doctor, nurse practitioner, or pharmacist doesn’t ask about your cannabis use, it’s crucial to share this information, whether you use it for health issues or just for enjoyment. Many prescription and over-the-counter medications, as well as alcohol, can interact with cannabis and lead to unexpected effects. We have limited evidence showing the medical benefits of cannabis, but this may change over time.”
The University of Michigan also noted that reclassifying cannabis as a Schedule III substance under the Controlled Substances Act (CSA) could encourage more clinical trials involving human volunteers. However, such research is currently limited due to federal restrictions.
Earlier this year, a separate study found that cannabis products may offer various therapeutic benefits for older adults, including improvements in health, well-being, sleep, and mood. The authors of this study, published in the journal Drugs and Aging, noted significant reductions in pain severity and interference for older patients reporting chronic pain as their main issue.
1. Medical Background of Atomizers Atomization technology has long been applied in the medical field, particularly in the treatment of respiratory conditions such as asthma and COPD. By converting active compounds into ultra-fine particles, atomizers deliver substances directly to the lungs for rapid absorption and high bioavailability.
August 1st, 20251. Medical Background of Atomizers Atomization technology has long been applied in the medical field, particularly in the treatment of respiratory conditions such as asthma and COPD. By converting active compounds into ultra-fine particles, atomizers deliver substances directly to the lungs for rapid absorption and high bioavailability.
August 1st, 2025Introduction As healthcare providers in the U.S. increasingly seek effective, reimbursable methods to help patients quit smoking, water-based nicotine inhalation products are emerging as a powerful new solution. These formulations offer both clinical effectiveness and regulatory advantages—making them ideal for pharmacy and clinic distribution under Medicare-supported cessation programs. Medicare Covers Up to $2,000 Per Patient […]
July 23rd, 2025Introduction As healthcare providers in the U.S. increasingly seek effective, reimbursable methods to help patients quit smoking, water-based nicotine inhalation products are emerging as a powerful new solution. These formulations offer both clinical effectiveness and regulatory advantages—making them ideal for pharmacy and clinic distribution under Medicare-supported cessation programs. Medicare Covers Up to $2,000 Per Patient […]
July 23rd, 2025Abstract Oil-based cannabinoids have long faced challenges such as low oral bioavailability (typically under 15%), poor formulation compatibility, and inconsistent onset. Water-based delivery systems—THCX, and RENICO—offer a new standard of performance, combining faster absorption, enhanced versatility, and broader consumer appeal. This article outlines the science and innovation behind these next-generation cannabinoid formats. The Limitations of
July 18th, 2025Abstract Oil-based cannabinoids have long faced challenges such as low oral bioavailability (typically under 15%), poor formulation compatibility, and inconsistent onset. Water-based delivery systems—THCX, and RENICO—offer a new standard of performance, combining faster absorption, enhanced versatility, and broader consumer appeal. This article outlines the science and innovation behind these next-generation cannabinoid formats. The Limitations of
July 18th, 2025U.S. marijuana interest groups are sounding the alarm over a House Republican budget proposal that, if passed by Congress, would outright ban marijuana-derived THC products at the federal level, including so-called THCA flower. U.S. Rep. Andy Harris, a Maryland Republican who chairs a key subcommittee on the bill, said the proposal, the Agriculture, Rural Development,
July 6th, 2025U.S. marijuana interest groups are sounding the alarm over a House Republican budget proposal that, if passed by Congress, would outright ban marijuana-derived THC products at the federal level, including so-called THCA flower. U.S. Rep. Andy Harris, a Maryland Republican who chairs a key subcommittee on the bill, said the proposal, the Agriculture, Rural Development,
July 6th, 2025The number of older Americans using vaping marijuana has nearly doubled in the past three years, according to new research supported by the American Association of Retired Persons (AARP).
November 17th, 2025The number of older Americans using vaping marijuana has nearly doubled in the past three years, according to new research supported by the American Association of Retired Persons (AARP).
November 17th, 2025
